LXRX — Lexicon Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Lexicon Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	272	152	86.7	138	170
Net Total Accounts Receivable
Net Total Receivables	56.5	0.395	0.014	0.028	1.01
Total Inventory
Prepaid Expenses
Total Current Assets	338	158	88.9	141	177
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	15.7	1.5	3.48	4.37	7.51
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	418	204	137	194	229
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	65.3	46.8	22.1	23.2	31.5
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	301	47.4	23.3	77.2	136
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	117	156	114	117	93.1
Total Liabilities & Shareholders' Equity	418	204	137	194	229
Total Common Shares Outstanding